Pancreatic Cancer Research

ResearcherUniversidade de São PauloActive in the last 2 years

Francisco Tustumi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6695-0496; OpenAlex author ID A5020933173. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2024: 2 papers · 2025: none · 2026: 1 paper

Papers 3

  1. Social Progress Index as a Determinant of Healthcare Access and Treatment in Pancreatic Cancer. Co-author DOI 10.3390/curroncol33060346↗
  2. IS THERE A ROLE FOR BILIODIGESTIVE BYPASS SURGERY IN TREATING CHOLESTASIS IN ADVANCED PANCREATIC CANCER? First author DOI 10.1590/0102-6720202400030e1823↗
  3. Concomitant or antecedent intraductal papillary mucinous neoplasm is not a prognostic factor in resected pancreatic cancer. Co-author DOI 10.21037/jgo-24-157↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lucas Cata Preta Stolzemburg · 2 shared papers, 2024–2026 · strength 0.50
  2. Pedro Luiz Serrano Usón · 2 shared papers, 2024–2026 · strength 0.46
  3. Guilherme Naccache Namur · 2 shared papers, 2024 · strength 0.40
  4. Felipe B. Maegawa · 1 shared paper, 2026 · strength 0.28
  5. Nelson Wolosker · 1 shared paper, 2026 · strength 0.28
  6. Ricardo Jureidini · 1 shared paper, 2024 · strength 0.22
  7. Mitesh J. Borad · 1 shared paper, 2024 · strength 0.18
  8. Diogo Diniz Gomes Bugano · 1 shared paper, 2024 · strength 0.18
  9. Fernando Moura · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.